Surface Markers and Translocations Flashcards
t(9;22)
B-ALL, poor prognosis, seen in adults (“Adults are more likely to “Phall”)
and CML
ABL (9) –> BCR (22) Philadelphia
t(12;21)
B-ALL, good prognosis, seen in adults
t(8;14)
Burkitt Lymphoma
cMyc (8) –> IgH (14)
t(11;14)
Mantle Cell Lymphoma (G1–>S)
Cyclin D or CCND1 (11) –> IgH (14)
t(14;18)
Follicular Lymphoma (B cells) BCl2 (18) --> IgH (14)
B-ALL gene mutation (children bad prognosis)
t(9;22)
B-ALL, gene mutation (adults, good prognosis)
t(12;21)
Burkitt Lymphoma gene mutaiton
t(8;14)
Mantle Cell Lymphoma gene mutation
t(11;14)
Cyclin D or CCND1 (11) –> IgH (14)
Follicular Lymphoma (B cells) gene mutation
t(14;18)
CD16 association
Fc Receptor on neutrophils. Decreased levels are a sign of “left shift” or release of immature cells in neutrophilic leukocytosis.
CD10, CD19, CD20, CD22 association
(And Tdt+) = B-ALL, the most common type of ALL
CD2 through CD8 association
(and TdT+) = T-ALL
CD10 negative
MPO+ exists on…
Myeloblasts (upregulated in AML)
Tdt+ exists on…
Lymphoblasts (Upregulated in ALL)
Increased IL-5 production associated with…
Eosinophelia, sign of allergic reaction, associated with Hodgkin Lymphoma
Basophilia associated with…
Associated with CML
Fc Receptor on neutrophils associated with what marker?
CD16
Decreased levels are a sign of “left shift” or release of immature cells in neutrophilic leukocytosis.
B-ALL surface marker
CD10, CD19, CD20, CD22, Tdt+
T-ALL surface marker
CD2 through CD8, Tdt+, CD10 NEGATIVE
Myeloblasts (upregulated in AML) surface marker
MPO+
Lymphoblasts (Upregulated in ALL) surface marker
Tdt+
Associated with CML…
Basophilia
t(15;17)
Acute promyelocytic Leukeia (an AML)
Retinoic acid receptor (17) –> 15
RAR disruption blocks maturation and promyelocytes (blasts) accumulate
- Auer Rods increase risk of DIC by activating coag. cascade
- Treated with ATRA, vit.A derivative
- may lead to ATRA syndrome